跳到正文

公司

Innovent

Innovent 的结构

Innovent

公司

7 个关联
同行竞争与合作
关系出现时间2026
Innovent公司 · 7 个关联
第 1 层

同行竞争与合作7

关系

箭头表示关系方向,可按业务类别筛选。

  • Innovent合作 →Eli Lilly
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09
      Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
      查看来源
  • Innovent合作 →Roche
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09
      Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
      查看来源
  • Innovent合作 →Takeda
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09
      Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
      查看来源
  • Innovent合作 →Pfizer
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09
      Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
      查看来源
  • Innovent合作 →Sanofi
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09
      Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
      查看来源
  • Innovent合作 →Incyte
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09
      Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
      查看来源
  • 事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-09
      Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
      查看来源

显示第 1 至 7 条,共 7 条

结论

结合来源阅读结论,展开条目查看证据。

事实证据 1
products launched in the market20 products

Innovent has launched 20 products in the market.

PR Newswire news releases · 2026-10-09

查看证据
  • 公司披露PR Newswire news releases2026-10-09
    Innovent has launched 20 products in the market.
    查看来源
事实证据 1
assets under nda review1 asset

It has 1 asset under NDA review, 5 assets in phase 3 or pivotal clinical trials, and 19 more molecules in early clinical stage.

PR Newswire news releases · 2026-10-09

查看证据
  • 公司披露PR Newswire news releases2026-10-09
    It has 1 asset under NDA review, 5 assets in phase 3 or pivotal clinical trials, and 19 more molecules in early clinical stage.
    查看来源
事实证据 1
assets in phase 3 or pivotal clinical trials5 assets

It has 1 asset under NDA review, 5 assets in phase 3 or pivotal clinical trials, and 19 more molecules in early clinical stage.

PR Newswire news releases · 2026-10-09

查看证据
  • 公司披露PR Newswire news releases2026-10-09
    It has 1 asset under NDA review, 5 assets in phase 3 or pivotal clinical trials, and 19 more molecules in early clinical stage.
    查看来源
事实证据 1
molecules in early clinical stage19 molecules

It has 1 asset under NDA review, 5 assets in phase 3 or pivotal clinical trials, and 19 more molecules in early clinical stage.

PR Newswire news releases · 2026-10-09

查看证据
  • 公司披露PR Newswire news releases2026-10-09
    It has 1 asset under NDA review, 5 assets in phase 3 or pivotal clinical trials, and 19 more molecules in early clinical stage.
    查看来源
事实证据 1
合作Eli Lilly

Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.

PR Newswire news releases · 2026-10-09

查看证据
  • 公司披露PR Newswire news releases2026-10-09
    Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
    查看来源
事实证据 1
合作Roche

Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.

PR Newswire news releases · 2026-10-09

查看证据
  • 公司披露PR Newswire news releases2026-10-09
    Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
    查看来源

显示第 1 至 6 条,共 11 条

市场与估值

估值数据需要 Pro 或 Research。

升级到 Pro 解锁

暂无: 公司信号 · 财务数据 · 披露文件 · 业绩指引